Skip to main content
SpringerLink
Log in

Nonradiological Treatment for Lung Tumors

  • Chapter
  • First Online:
Interventional Oncology

  • 1103 Accesses

Abstract

Lung cancer is a major public health problem. In the USA, approximately 220,000 patients are diagnosed annually and 160,000 die, far more than from prostate or breast cancer (American Cancer Society 2010 Cancer Statistics). Worldwide, lung cancer is the leading cause of cancer mortality, and the World Health Organization estimates 1.3 million deaths per year. The 5-year survival rate is only approximately 15%, and this survival has not changed dramatically over the past three decades.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dempke WC, Suto T, Reck M. Targeted therapies for non-small cell lung cancer. Lung Cancer. 2010;67(3):257–74. Epub 2009 Nov 14.

    Google Scholar 

  2. AJCC Cancer Staging Handbook. American Joint Committee On Cancer. 7th ed. New York: Springer; 2010.

    Google Scholar 

  3. Azzoli CG, Baker Jr S, Temin S, Pao W, Aliff T, Brahmer J, et al. American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol. 2009;27(36):6251–66. Epub 2009 Nov 16.

    Article  PubMed  CAS  Google Scholar 

  4. Robinson LA, Ruckdeschel JC, Wagner H Jr, Stevens CW, American College of Chest Physicians. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd ed.). Chest. 2007;132(3 Suppl):243 S–65 S.

    Google Scholar 

  5. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology, non-small cell lung cancer, v2.2010. http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf. Accessed 1 Dec 2010.

  6. Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, Desch CE, et al., Cancer Care Ontario, American Society of Clinical Oncology. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol. 2007;25(34):5506–18. Epub 2007 Oct 22.

    Google Scholar 

  7. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol. 2010;28(1):126–31. Epub 2009 Nov 16.

    Article  PubMed  Google Scholar 

  8. Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest. 2007;132(1):193–9. Epub 2007 May 15.

    Article  PubMed  Google Scholar 

  9. Morrison R, Deeley TJ, Cleland WP. The treatment of carcinoma of the bronchus: a clinical trial to compare surgery and supervoltage radiotherapy. Lancet. 1963;281(7283):683–4.

    Article  Google Scholar 

  10. National Institute for Clinical Excellence. The diagnosis and treatment of lung cancer: methods, evidence, and guidance. http://www.nice.org.uk/nicemedia/pdf/cg024fullguideline.pdf. Accessed 1 Dec 2010.

  11. Jensik RJ, Faber LP, Millov FJ, et al. Segmental resection for lung cancer – a fifteen-year experience. J Thorac Cardiovasc Surg. 1973;66:563–72.

    PubMed  CAS  Google Scholar 

  12. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60(3):615–22. discussion 622–3.

    Article  PubMed  CAS  Google Scholar 

  13. Lederle FA. Lobectomy versus limited resection in T1 N0 lung cancer. Ann Thorac Surg. 1996;62(4):1249–50.

    Article  PubMed  CAS  Google Scholar 

  14. Okada M, Yoshikawa K, Hatta T, Tsubota N. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann Thorac Surg. 2001;71(3):956–60. discussion 961.

    Article  PubMed  CAS  Google Scholar 

  15. Koike T, Yamato Y, Yoshiya K, Shimoyama T, Suzuki R. Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg. 2003;125(4):924–8.

    Article  PubMed  Google Scholar 

  16. Nakamura H, Kawasaki N, Taguchi M, Kabasawa K. Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis. Br J Cancer. 2005;92(6):1033–7.

    Article  PubMed  CAS  Google Scholar 

  17. Chamogeorgakis T, Ieromonachos C, Georgiannakis E, Mallios D. Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients? Interact Cardiovasc Thorac Surg. 2009;8(3):364–72. Epub 2008 Jul 18.

    Article  PubMed  Google Scholar 

  18. Mery CM, Pappas AN, Bueno R, Colson YL, Linden P, Sugarbaker DJ, et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest. 2005;128(1):237–45.

    Article  PubMed  Google Scholar 

  19. Lyons G, Quadrelli S, Silva C, Vera K, Iotti A, et al. Analysis of survival in 400 surgically resected non-small cell lung carcinomas: towards a redefinition of the T factor. J Thorac Oncol. 2008;3(9):989–93.

    Article  PubMed  Google Scholar 

  20. British Thoracic Society, Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax. 2001;56(2):89–108.

    Google Scholar 

  21. Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT, American College of Chest Physicians. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd ed.). Chest. 2007;132(3 Suppl):161 S–77 S.

    Google Scholar 

  22. Lee W, Daly BD, DiPetrillo TA, Morelli DM, Neuschatz AC, Morr J, et al. Limited resection for non-small cell lung cancer: observed local control with implantation of I-125 brachytherapy seeds. Ann Thorac Surg. 2003;75(1):237–42. discussion 242–3.

    Article  PubMed  Google Scholar 

  23. Santos R, Colonias A, Parda D, Trombetta M, Maley RH, Macherey R, et al. Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non-small-cell lung cancer. Surgery. 2003;134(4):691–7. discussion 697.

    Article  PubMed  Google Scholar 

  24. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer. 2003;41(1):1–11.

    Article  PubMed  Google Scholar 

  25. Wisnivesky JP, Bonomi M, Henschke C, Iannuzzi M, McGinn T. Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. Chest. 2005;128(3):1461–7.

    Article  PubMed  Google Scholar 

  26. Mehta M, Scrimger R, Mackie R, Paliwal B, Chappell R, Fowler J. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2001;49(1):23–33.

    Article  PubMed  CAS  Google Scholar 

  27. Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys. 2005;61(2):318–28.

    Article  PubMed  Google Scholar 

  28. Slotman BJ, Antonisse IE, Njo KH. Limited field irradiation in early stage (T1-2 N0) non-small cell lung cancer. Radiother Oncol. 1996;41(1):41–4.

    Article  PubMed  CAS  Google Scholar 

  29. Bush DA, Slater JD, Bonnet R, Cheek GA, Dunbar RD, Moyers M, et al. Proton-beam radiotherapy for early-stage lung cancer. Chest. 1999;116(5):1313–9.

    Article  PubMed  CAS  Google Scholar 

  30. Bush DA, Slater JD, Shin BB, Cheek G, Miller DW, Slater JM. Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest. 2004;126(4):1198–203.

    Article  PubMed  Google Scholar 

  31. Nihei K, Ogino T, Ishikura S, Nishimura H. High-dose proton beam therapy for Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;65(1):107–11.

    Article  PubMed  Google Scholar 

  32. Hata M, Tokuuye K, Kagei K, Sugahara S, Nakayama H, Fukumitsu N, et al. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. Int J Radiat Oncol Biol Phys. 2007;68(3):786–93. Epub 2007 Mar 26.

    Article  PubMed  Google Scholar 

  33. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys. 2005;63(4):1010–5. Epub 2005 Aug 22.

    Article  PubMed  Google Scholar 

  34. Timmerman R et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(110):1070–6.

    Article  PubMed  CAS  Google Scholar 

  35. Wulf J, Baier K, Mueller G, Flentje MP. Dose–response in stereotactic irradiation of lung tumors. Radiother Oncol. 2005;77(1):83–7. Epub 2005 Oct 4.

    Article  PubMed  Google Scholar 

  36. Hara R, Itami J, Kondo T, Aruga T, Uno T, Sasano N, et al. Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors. Cancer. 2006;106(6):1347–52.

    Article  PubMed  Google Scholar 

  37. Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007;2(7 Suppl 3):S94–100.

    Article  PubMed  Google Scholar 

  38. Nagata Y, Hiraoka M, Mizowaki T, Narita Y, Matsuo Y, Norihisa Y, et al. Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group. Int J Radiat Oncol Biol Phys. 2009;75(2):343–7.

    Article  PubMed  Google Scholar 

  39. Sahn SA, Nett LM, Petty TL. Ten year follow-up of a comprehensive rehabilitation program for severe COPD. Chest. 1980;77(2 Suppl):311–4.

    Article  PubMed  CAS  Google Scholar 

  40. D’Cunha J, Herndon JE 2nd, Herzan DL, Patterson GA, Kohman LJ, Harpole DH et al., Cancer and Leukemia Group B. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial. Lung Cancer. 2005;48(2):241–6. Epub 2005 Jan 4.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, MD Anderson Cancer Center Orlando, Orlando, FL, USA

    Tomas Dvorak

  2. Department of Radiation Oncology, Rhode Island Hospital, Providence, RI, USA

    Thomas A. DiPetrillo

Authors
  1. Tomas Dvorak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas A. DiPetrillo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomas Dvorak .

Editor information

Editors and Affiliations

  1. Massachusetts General Hospital, Department of Radiology, Harvard Medical School, Fruit St. 55, Boston, 02114, Massachusetts, USA

    Peter Mueller

  2. Dept. Radiology, Guy’s and St. Thomas’ Hospital, Lambeth Palace Road, London, SE1 7EH, United Kingdom

    Andreas Adam

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Dvorak, T., DiPetrillo, T.A. (2012). Nonradiological Treatment for Lung Tumors. In: Mueller, P., Adam, A. (eds) Interventional Oncology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1469-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1469-9_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1468-2

  • Online ISBN: 978-1-4419-1469-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation